p63-driven nuclear accumulation of β-catenin is not a frequent event in human neoplasms

Pathology Research and Practice

Volumn 199, Issue 12, 2003, Pages 785-793

  Reis Filho, Jorge S ^a,b   Simpson, Pete T ^a   Fulford, Laura G ^a,c   Martins, Albino ^b   Schmitt, Fernando C ^d,e  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MINHO   (Portugal)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF PORTO   (Portugal)

^e University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ISOPROTEIN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PROTEIN P63; WNT PROTEIN;

ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CARCINOGENICITY; CELL MEMBRANE; CELL PROLIFERATION; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLON TUMOR; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVARY CARCINOMA; OVARY TUMOR; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TUMOR CELL LINE; VARIANCE;

EID: 1242307857     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00497     Document Type: Article

References (33)

1. Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G, Doglioni C (2001) p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 25: 1054-1060
2. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, Gemmill RM, Drabkin HA, Franklin WA (2002) High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 20: 2417-2428
3. Brinck U, Ruschenburg I, Di Como CJ, Buschmann N, Betke H, Stachura J, Cordon-Cardo C, Korabiowska M (2002) Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas. Int J Mol Med 10: 707-711
4. Chesire DR, Ewing CM, Sauvageot J, et al. (2000) Detection and analysis of beta-catenin mutations in prostate cancer. Prostate 45: 323-334
5. De Laurenzi V, Rossi A, Terrinoni A, Barcaroli D, Levrero M, Costanzo A, Knight RA, Guerrieri P, Melino G (2000) p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun 273: 342-346
6. Demunter A, Libbrecht L, Degreef H, De Wolf-Peeters C, van den Oord JJ (2002) Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Mod Pathol 15: 454-461
7. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8: 494-501
8. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A (1993) β-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 155: 527-536
9. Ghioni P, Bolognese F, Duijf PH, Van Bokhoven H, Mantovani R, Guerrini L (2002) Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol Cell Biol 2002 22: 8659-8668
10. Gillett CE, Miles DW, Ryder K, Skilton D, Liebman RD, Springall RJ, Barnes DM, Hanby AM (2001) Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol 193: 433-441
11. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR (1999) Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 80: 1046-1051
12. Karbova E, Davidson B, Metodiev K, Trope CG, Nesland JM (2002) Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma. Int J Surg Pathol 10: 175-180
13. Kaufmann O, Fietze E, Mengs J, Dietel M (2001) Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116: 823-830
14. Koga F, Kawakami S, Kumagai J, Takizawa T, Ando N, Arai G, Kageyama Y, Kihara K (2003) Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. Br J Cancer 88: 740-747
15. Koster MI, Huntzinger KA, Roop DR (2002) Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation. J Investig Dermatol Symp Proc 7: 41-45
16. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713
17. Moreno-Bueno G, Gamallo C, Perez-Gallego L, de Mora JC, Suarez A, Palacios J (2001) β-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 10: 116-122
18. Morin PJ (1999) beta-catenin signaling and cancer. Bioessays 21: 102-1030
19. Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, Zhanxiang W, Sjostrom B, Dahlqvist A, Coates PJ (2002) Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 198: 417-427
20. Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, Poliak N, Califano J, Trink B, Ratovitski E, Sidransky D (2002) DNp63 induces β-catenin nuclear accumulation and signaling. Cancer Cell 1: 369-379
21. Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G (2002) p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 198: 100-109
22. Pirinen RT, Hirvikoski P, Johansson RT, Hollmen S, Kosma VM (2001) Reduced expression of a-catenin, b-catenin, and g-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 54: 391-395
23. Reis-Filho JS, Schmitt FC (2002) Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 9: 280-289
24. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV, Schmitt FC (2003) Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 11: 1-8
25. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gärtner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443: 122-132
26. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC (2002) P63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 29: 517-523
27. Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER (1999) Frequent nuclear/cytoplasmic localization of b-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154: 325-329
28. Sharpe C, Lawrence N, Martinez Arias A (2001) Wnt signalling: a theme with nuclear variations. Bioessays 23: 311-318
29. Sormunen RT, Leong AS, Vaaraniemi JP, Fernando SS, Eskelinen SM (1999) Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model. J Pathol 187: 416-423
30. Wang BY, Gil J, Kaufman D, Gan L, Kohtz DS, Burstein DE (2002) P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 33: 921-926
31. Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, Dong SM, Guo Z, Benoit N, Cohen Y, Rechthand P, Califano J, Moon CS, Ratovitski E, Jen J, Sidransky D, Trink B (2003) DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63: 2351-2357
32. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718
33. Yano H, Hara A, Takenaka K, Nakatani K, Shinoda J, Shimokawa K, Yoshimi N, Mori H, Sakai N (2000) Differential expression of beta-catenin in human glioblastoma multiforme and normal brain tissue. Neurol Res 22: 650-656